$2.3B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ERAS Erasca Inc | 12.2M | +9.0% | $223M | 9.6% |
| 2 | ABIVAX SA Abivax Sa | 1.0M | +51.7% | $136M | 5.9% |
| 3 | RVMD Revolution Medicines Inc | 700,000 | −65.0% | $131M | 5.6% |
| 4 | IDYA Ideaya Biosciences Inc | 3.0M | −13.0% | $112M | 4.8% |
| 5 | BNTX Biontech Se | 1.0M | — | $94M | 4.1% |
| 6 | VERA Vera Therapeutics Inc | 2.2M | — | $94M | 4.1% |
| 7 | TNGX Tango Therapeutics Inc | 2.9M | −5.0% | $89M | 3.8% |
| 8 | PRAX Praxis Precision Medicines I | 260,000 | −8.8% | $87M | 3.7% |
| 9 | CLDX Celldex Therapeutics Inc New | 2.1M | +366.7% | $78M | 3.4% |
| 10 | DNTH Dianthus Therapeutics Inc | 800,000 | +100.0% | $78M | 3.4% |
| 11 | CGON Cg Oncology Inc | 1.0M | +73.9% | $71M | 3.1% |
| 12 | IRON Disc Medicine Inc | 875,000 | +56.2% | $64M | 2.8% |
| 13 | MAZE Maze Therapeutics Inc | 1.9M | +56.7% | $58M | 2.5% |
| 14 | DYN Dyne Therapeutics Inc | 2.5M | +82.1% | $57M | 2.4% |
| 15 | MLTX Moonlake Immunotherapeutics | 2.7M | +78.3% | $52M | 2.2% |
| 16 | OCUL Ocular Therapeutix Inc | 5.3M | +37.7% | $52M | 2.2% |
| 17 | DSGN Design Therapeutics Inc | 3.0M | +53.8% | $43M | 1.9% |
| 18 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 3.2M | +0.0% | $40M | 1.7% |
| 19 | BLTE Belite Bio Inc | 250,000 | — | $38M | 1.7% |
| 20 | QUIT Achieve Life Science Inc | 5.4M | — | $35M | 1.5% |
| 21 | TRVI Trevi Therapeutics Inc | 1.9M | −21.7% | $35M | 1.5% |
| 22 | COGT Cogent Biosciences Inc | 900,000 | — | $35M | 1.5% |
| 23 | AVBP Arrivent Biopharma Inc | 1.0M | +185.7% | $35M | 1.5% |
| 24 | CBIO Crescent Biopharma Inc. | 1.9M | +293.8% | $34M | 1.5% |
| 25 | CMPS Compass Pathways Plc | 2.2M | — | $32M | 1.4% |
| 26 | MLYS Mineralys Therapeutics Inc | 1.1M | — | $28M | 1.2% |
| 27 | REPL Replimune Group Inc | 2.5M | — | $28M | 1.2% |
| 28 | XENE Xenon Pharmaceuticals Inc | 450,000 | +0.0% | $27M | 1.2% |
| 29 | GPCR Structure Therapeutics Inc | 500,000 | +0.0% | $27M | 1.2% |
| 30 | IMVT Immunovant Inc | 665,000 | −38.1% | $26M | 1.1% |
| 31 | JBIO Jade Biosciences Inc | 1.1M | +181.2% | $25M | 1.1% |
| 32 | ELVN Enliven Therapeutics Inc | 465,000 | −13.9% | $24M | 1.0% |
| 33 | MANE Veradermics Inc | 180,000 | +620.0% | $22M | 1.0% |
| 34 | AVTX Avalo Therapeutics Inc | 1.1M | +283.3% | $21M | 0.9% |
| 35 | RCUS Arcus Biosciences Inc | 650,000 | −45.8% | $20M | 0.9% |
| 36 | SMMT Summit Therapeutics Inc | 1.4M | — | $20M | 0.8% |
| 37 | IMCR Immunocore Hldgs Plc | 600,000 | −60.0% | $19M | 0.8% |
| 38 | LBRX Lb Pharmaceuticals Inc | 585,000 | −36.1% | $19M | 0.8% |
| 39 | NERV Minerva Neurosciences Inc | 3.3M | +2.3% | $18M | 0.8% |
| 40 | FTH Faeth Therapeutics Inc | 722,020 | +2306.7% | $18M | 0.8% |
| 41 | CRSP Crispr Therapeutics Ag | 300,000 | — | $16M | 0.7% |
| 42 | DBVT Dbv Technologies S A | 915,000 | — | $15M | 0.6% |
| 43 | PBLS Parabilis Medicines Inc | 525,000 | — | $14M | 0.6% |
| 44 | RYTM Rhythm Pharmaceuticals Inc | 125,000 | −72.2% | $14M | 0.6% |
| 45 | VOR Vor Biopharma Inc | 650,000 | −13.3% | $12M | 0.5% |
| 46 | SRRK Scholar Rock Hldg Corp | 200,000 | — | $11M | 0.5% |
| 47 | IMMX Immix Biopharma Inc | 1.0M | −18.4% | $10M | 0.4% |
| 48 | QTTB Q32 Bio Inc | 800,000 | — | $10M | 0.4% |
| 49 | ODTX Odyssey Therapeutics Inc | 521,736 | — | $10M | 0.4% |
| 50 | ANNX Annexon Inc | 1.5M | — | $9M | 0.4% |